S epsis, the host response to infection, may lead to severe sepsis that is associated with multiple organ failure as a consequence of the combination of redistribution of blood, microvascular failure, constriction, obstruction, and permeability changes leading to failure of oxygen delivery (1) . In addition, mitochondrial damage and dysfunction cause "metabolic" hypoxia, and reactive nitrogen and oxygen species exert direct cytotoxic effects on membranes, lipids, nucleic acids, and proteins contributing to the failure of organs including lung, heart, liver, and kidney. There is much evidence for redox imbalance and oxidative stress in sepsis, demonstrated by increased markers of oxidative damage (for review see 2, 3). When sepsis is associated with refractory hypotension due to an excessive vasodilation despite adequate fluid resuscitation, the syndrome is defined as septic shock (1) .
The activation of a number of host mediator systems, including the cytokine, leukocyte, and hemostatic networks, may lead to overproduction of nitric oxide (NO). Large amounts of NO, generated by enhanced expression of the inducible NO synthase (iNOS), have been detected in human vessels from septic patients (4) and from endotoxic rats (5) . These are implicated in symptoms observed in septic shock patients and animals, including tissue hypoperfusion and hypoxia, lactic acidosis, oliguria, and vascular hyporeactivity.
Recently, it has been shown that microparticles (MPs) derived from the plasma of malaria-infected mice induce potent activation of macrophages in vitro and may contribute to malaria infectioninduced inflammation (6) . Also, Soriano et al (7) have shown that MPs could be Objective: Septic shock is characterized by hypotension and multiple organ failure after infection of microorganisms. Septic shock patients display high levels of circulating microparticles. These are small vesicles released from the plasma membrane of activated or apoptotic cells. Here, we have investigated the effects of in vivo injection of microparticles from nonseptic or septic subjects on protein expression in mouse tissues.
Design: Prospective, controlled experiments. Setting: Animal basic science laboratory. Subjects: Male Swiss mice were randomly assigned to one of two groups: 11 animals injected with microparticles isolated from healthy subjects and 15 animals injected with microparticles isolated from septic patients.
Interventions: Microparticles were extracted from whole blood of septic and nonseptic subjects and were intravenously injected in mice. After 24 hrs, mice were killed and heart, lungs, liver, and kidneys were isolated for Western blot assays. Organs were also used for direct measurements of nitric oxide and superoxide anion production by electron paramagnetic resonance.
Measurements and Main Results:
In heart and lungs, microparticles from septic shock patients increased the expression of endothelial and inducible nitric oxide synthases, cyclooxygenase-2, and nuclear factor-B. However, extracellular superoxide dismutase was only increased in the heart. These effects were associated either with a greater oxidative or nitrative stress in heart and lungs, without affecting nitric oxide production. The liver exhibited an increase in oxidative stress linked to decreased endothelial nitric oxide synthase and manganese superoxide dismutase expression. However, cyclooxygenase-2 expression and IB␣ phosphorylation were decreased. Septic microparticles did not change superoxide anion and nitric oxide productions in kidneys.
Conclusions: Results suggest that microparticles from septic shock patients exert pleiotropic and differential effects depending on target tissues with regard to the expression of proinflammatory proteins related with nitrative and oxidative stresses. Thus, microparticles might participate in organ dysfunction observed in septic shock patients. (Crit Care Med 2011; 39:1739 -1748) KEY WORDS: microparticles; sepsis; shock; nitric oxide; oxidative stress; inflammation considered as markers of inflammation in patients with septic shock. Furthermore, Nieuwland et al (8) have reported elevated levels of circulating and procoagulant MPs in meningococcal sepsis that can participate in the disseminated intravascular coagulation. MPs are small vesicles shed from the blebbing plasma membrane of various cell types during activation or apoptosis (9) . Recently, we have shown that circulating MPs are significantly increased in septic patients compared to nonseptic subjects and in particular, platelet-and endothelialderived MPs, as well as, L-selectin ϩ and P-selectin ϩ MPs (10). Furthermore, MPs from septic patients are protective against vascular hyporeactivity to maintain a vasoconstrictive response in mice treated with lipopolysaccharide (10). To our knowledge, the role played by MPs in different target organs has not been assessed, although they regulate vascular function in septic shock patients. Furthermore, their role with regard to tissular changes either of oxidative or nitrative stress during sepsis is not known. Therefore, the aim of the present study was to assess the in vivo pathophysiological relevance of MPs after they were intravenously injected into mice by measuring NO and superoxide anion (O 2 Ϫ ) productions in heart, liver, lungs, and kidneys.
MATERIALS AND METHODS

Patients and Blood Cell Preparation
This study was approved by the Ethics Committee of the Société de Réanimation de Langue Française. The study included patients with (n ϭ 15) or without (n ϭ 11) septic shock. Septic shock was defined according to standard criteria of International Sepsis Definitions Conference, 2001 (11), i.e., a state of acute circulatory failure characterized by persistent arterial hypotension unexplained by other causes. Baseline characteristic of patients with septic shock (male: 93%, female: 7%) are shown in Table 1 . The sources of sepsis are also shown in Table 1 . Patients housed in the intensive care unit without evidence of infection and with normal hemodynamics (blood pressure was within the normal range) were considered as controls (male: 73%, female: 27%). Peripheral blood (20 mL) from nonseptic and septic patients was collected during the early phase of septic shock (10 Ϯ 4 hrs after enrollment in the intensive care unit) from a peripheral vein. MPs were isolated and MP subpopulations were discriminated according the expression of membranespecific antigens and samples were analyzed in a flow cytometer 500 MPL system (Beckman Coulter, Villepinte, France) as previously reported (10) . The MP concentration for injection was determined by flow cytometry. As previously described (10), septic patients displayed elevated circulating levels of MPs from platelets and endothelial cells, and MPs expressing CD62L and CD62P. Levels of endotoxin were assessed in all MP preparations with a Limulus Amebocyte Lysate kit (QCL-1000; Lonza, Walkersville, MD) and were found to be below the lower detection limit of the kit (Ͻ0.1 endotoxin unit/mL).
NO Determination by Electron Paramagnetic Resonance
All animal studies were carried out using approved institutional protocols and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). Male Swiss mice (8 -10 wks old) were treated in vivo by injection into the tail vein of MPs at the circulating levels of MPs detected in the blood of septic or nonseptic patients (range: 1451-69,485 MPs/l of plasma), as previously described (10) . It should be noted that independently of the circulating level, all septic MPs displayed hyper-reactivity in aortic rings (10) . Under these conditions, we did not see any mortality or clinical signs of sepsis in injected mice.
Hearts, livers, lungs, and kidneys were obtained from mice treated either with MPs from nonseptic or septic patients during 24 hrs. Then, tissues were dissected and incubated for 30 mins in Krebs-HEPES buffer containing: 
O 2 ؊ Spin-Trapping
After mice pretreated with nonseptic and septic MPs were killed, heart, liver, lungs, and kidneys were allowed to equilibrate in deferoxamine-chelated Krebs-HEPES solution containing 1-hydroxy-3methoxycarbonyl-2,2,5,5-tetramethylpyrrolidin (CMH, Noxygen, Germany) (500 M), deferoxamine (25 M), and diethyldithiocarbamate (5 M) under constant temperature (37°C) for 45 mins. Samples were then frozen in liquid nitrogen and analyzed by electron paramagnetic resonance. Values are expressed in unit/mg weight of dried tissue.
Western Blotting
After treatment, tissues were homogenized and lysed. Proteins (80 g) were separated on 10% SDS-PAGE. Blots were probed with antiendothelial NOS (eNOS), anti-inducible NOS (iNOS), anti-cyclooxygenase-2 (COX-2) (BD Biosciences, San Jose, CA), anti-cyclooxygenase-1 (COX-1) (Santa Cruz Biotechnology, Santa Cruz, CA), anti-p65 subunit of nuclear factor-B (NF-B) (Abcam, Cambridge, UK), anti-phospho-IB ␣ (p-IB␣) (US Biological, Swampscott, MA), anti-manganese superoxide dismutase (Mn-SOD), anti-copper/zinc superoxide dismutase (Cu/Zn-SOD), anti-extracellular superoxide dismutase (EC-SOD) (Stressgen Biotechnologies Corporation, Victoria, Canada), and anti-nitrotyrosine (Cayman Chemical, Ann Arbor, MI) antibodies. A polyclonal rabbit anti-␤-actin antibody (Sigma-Aldrich, St Quentin Fallavier, France) was used for visualization of protein gel loading. The membranes were then incubated with the appropriate horseradish peroxidase-conjugated secondary antibody (Amersham Biosciences, Piscataway, NJ), and the protein-antibody complexes were detected by Enhanced Chemiluminescence Plus (Amersham Biosciences).
Data Analysis
Data are represented as mean Ϯ SEM, n represents the number of animals. Statistical analyses were performed by two-way analysis of variance or nonparametric Mann-Whitney U tests depending on the number of samples. p Ͻ .05 was considered to be statistically significant.
RESULTS
A summary of the effects of MPs on protein expression in the heart, lung, liver, and kidney is shown in Table 2 .
Effects of MPs on Protein Expression in Heart. Hearts taken from mice treated with septic MPs exhibited enhanced expression of enzymes related to NO and prostanoid productions, eNOS and iNOS, and COX-1 and COX-2 compared with those taken from nonseptic MP-treated mice. These effects were associated with an increase in NF-B expression without modification of p-IB␣. Concerning the enzymes implicated in oxidative stress, treatment with septic MPs elicited a greater expression of EC-SOD, but not Cu/Zn-SOD or Mn-SOD (Fig. 1) .
Effects of MPs on Protein Expression in Lungs.
In lungs from septic MPtreated mice (Fig. 2) , eNOS expression was increased, as well as expression of the inducible proteins iNOS and COX-2, but not COX-1. In addition, NF-B expression was augmented whereas p-IB␣ was significantly reduced. No effect on SOD pro- Figure 3 , livers from septic MP-treated mice exhibited lower expressions of eNOS and COX-2. Expressions of iNOS, COX-1, and NF-B were not modified in livers from septic MP-treated mice compared with those from nonseptic MP-treated mice. Furthermore, p-IB␣ was significantly reduced. Although MPs from septic patients induced a slight, but significant, decrease in Mn-SOD expression, the other SOD proteins were not modified.
Effects of MPs on Protein Expression in Kidneys. As shown in Figure 4 , kidneys from septic MP-treated mice exhibited a significant decrease of eNOS expression, while expression of COX-1, iNOS, and COX-2 were not modified. Among other proteins studied, only p-IB␣ was reduced and Cu/Zn-SOD was increased in response to septic MP treatment.
Effects of MPs on Tissue NO and O 2
Ϫ
Production and Nitrative Stress. NO measurement by electron paramagnetic resonance showed that septic MPs did not affect NO production in heart, liver, lungs, and kidneys, compared with nonseptic MP-treated mice. Regarding oxidative stress, O 2 Ϫ production was greater in heart and liver but not in lungs and kidneys from mice treated with septic MPs vs. nonseptic MPs (Fig. 5) .
The reaction between NO and O 2 Ϫ generates peroxynitrite. Therefore, we evaluated its formation in tissues by studying nitration of proteins, a subsequent step to peroxynitrite formation, using specific antibodies raised against nitrotyrosine. Interestingly, septic MPs strongly increased nitration of proteins in lungs, but not in other tissues (heart, liver, and kidneys) (Fig. 6) .
DISCUSSION
The present study shows that intravenous injection of MPs obtained from early stage septic shock patients into mice exerts differential effects on target tissues, including heart, liver, lungs, and kidneys with regard to proteins related to NO release and O 2 Ϫ production, as well as COX. In heart and lungs, the expression of proinflammatory proteins (iNOS, COX-2, and NF-B) was increased. However, the SOD isoform EC-SOD was only increased in the heart. These effects were associated with either a greater oxidative or nitrative stress in heart and lungs, respectively, without affecting tissular NO production. The liver exhibited an increase in oxidative stress linked with decreased eNOS and Mn-SOD, despite reduced expression of COX-2 and phosphorylation of IB␣. Finally, kidneys were the least affected, since septic MPs did not change O 2 Ϫ and NO production. Recently, we reported increased circulating levels of MPs in patients with septic shock compared to nonseptic patients (10) , and this may predict a more favorable outcome in severe sepsis in terms of mortality rate and organ dysfunction (7) . In the present study, we provide evidence that heterologous injection in mice of MPs obtained from septic shock patients compared to injection of MPs obtained from nonseptic shock patients may induce deleterious effects in different target tissues, including heart, lung, and liver. These changes are related to oxidative and nitrative stresses, despite the fact that they maybe protective in counteracting the drop in peripheral resistance and progressive hypotension during severe sepsis (10) , under the experimental conditions used. Very recently, we found that rats with sepsis induced by peritonitis exhibit a specific phenotype of MPs, with MPs from leukocytes increased. Inoculation of these MPs in healthy rats reproduced hemodynamic, septic inflammatory patterns associated with oxidative and nitrative stresses in heart and aorta (12) . Although septic MPs from humans (10) or rats (11) exert different effects in terms of oxidative and nitrative stresses in the aorta, they exhibit similar effects in the heart.
Whereas constitutive NOS appears to be involved in the physiologic regulation of myocardial contractility through interaction between endothelial cells and cardiomyocytes (13), iNOS is responsible for Figure 2 . Effects of microparticles from nonseptic (NonSMPs) or septic (SMPs) subjects on protein expression in lungs. Mice were injected with MPs for 24 h and then killed, and lungs were isolated for analysis of protein expressions. Blots were probed with anti-endothelial nitric oxide synthase (eNOS), anti-inducible nitric oxide synthase (iNOS), anti-cyclooxygenase-1 (COX-1), anti-cyclooxygenase-1 (COX-2), anti-nuclear factor-B (NF-B), anti-phospho-IB␣ (p-IB␣), anti-copper/zinc superoxide dismutase (Cu/Zn-SOD), anti-manganese superoxide dismutase (Mn SOD), or anti-extracellular superoxide dismutase (EC-SOD) antibodies. Data are representative of nine separate blots, and the densitometry values are expressed in arbitrary units (AU) as mean Ϯ SEM * p Ͻ .05, ** p Ͻ .01, *** p Ͻ .001 vs. NonSMPs. the larger component of the prolonged myocardial depression during sepsis. Upon septic MP treatment, no increase in NO level was detected in the heart despite eNOS and iNOS overexpression. In this tissue, it is possible that the strong increase in O 2 Ϫ production induced by septic MPs decreases the bioavailability of NO, as we previously described in metabolic syndrome (14) . Also, uncoupling of NOS may explain the lack of detection of NO production. In fact, both eNOS and iNOS uncoupling can contribute to increases in O 2 Ϫ (15, 16). Thus, in the heart, enhanced expression of the two isoforms of NOS by septic MPs may account for the increase in O 2 Ϫ but not NO production. We have previously shown that injection of MPs isolated from rats with peritonitis increased both NO and O 2 Ϫ in MP-inoculated rats (11) . These discrepancies suggest that the different origin of MPs (peritonitis in rats vs. pulmonary infection mainly in septic patients) could account for the different regulation of NO production. Nevertheless, the cellular targets of septic MPs remain to be determined, whether they originated from cardiomyocytes or inflammatory cells infiltrated in the myocardium.
In lungs, we can speculate that the scavenging of NO by O 2 Ϫ to produce peroxynitrite is a key mechanism that decreases NO bioavailability in lungs. This hypothesis is confirmed by the increase in nitration of proteins in lungs from mice treated with septic MPs. It was shown that several proteins were nitrated in lungs from mice treated with septic MPs. Although the identity of these proteins has not been assessed, their molecular weights (72, 42, 35, 31, 25, and 9 kDa) were similar to those of COX-2, actin or extracellular signalrelated kinase mitogen-activated protein kinase, Mn-SOD, caveolin, and ubiquitin. Indeed, nitration of these proteins may have critical consequences in pathophysiology of the lung during sepsis. In heart as well as in lungs, COX-2 expression was increased. Indeed, COX-2 is overexpressed in hearts from septic rats and this is associated with heart injury (17) . Also, in septic shock rats, COX-2 metabolites are involved in the alterations of L-type Ca 2ϩ currents in myocytes (18). Marshall et al (19) have shown increased COX-2 levels in lungs from lipopolysaccharide-injected rats. Altogether, these results suggest that septic MPs may be responsible, at least in part, for the overexpression of COX-2 described in heart and lungs during sepsis and they may account for the deleterious effects of COX metabolites in these tissues.
Hepatic dysfunction and acute renal failure occur in the first hours after the initial injury as a result of a decrease in portal and hepatic blood flows (20, 21) . Although it is established that iNOS is induced in the liver and kidney during septic shock (22, 23) , septic MP treatment affected neither NO production nor iNOS expression in liver, even both eNOS and COX-2 expressions were reduced. eNOS deficiency increases susceptibility to acute renal failure during sepsis (24) . Thus, septic MPs may have a deleterious effect on hepatic and renal function by acting at the endothelial level, although they did not affect tissular NO production.
Despite no changes or decreases in IB␣ phosphorylation observed in all tissues, NF-B, iNOS, and COX-2 expressions were increased in heart and lungs. It is possible that activation of IB␣ might be delayed compared to activation of downstream proteins or that upregulation of iNOS and COX-2 observed in tissues from mice treated with septic MPs involves transcription factors other than NF-B.
Regarding the enzymes controlling oxidative stress, expression of EC-SOD was strongly increased in heart treated with septic MPs, and this was associated with O 2 Ϫ overproduction. EC-SOD is the only antioxidant enzyme that scavenges O 2 Ϫ specifically in the extracellular compartment. The fact that O 2 Ϫ levels increase concomitantly with the enhancement of EC-SOD suggests that the overproduction of O 2 Ϫ might induce an upregulation of EC-SOD expression to compensate the increase in oxidative stress. Another explanation is that the gain of EC-SOD function can be associated with deleterious effects as observed in other models. Indeed, the gain of SOD function is accompanied by motor neuron disease in transgenic mice (25) and atherosclerotic plaque development in apolipoprotein E-deficient and lowdensity lipoprotein-deficient mice (26) . In the liver, septic MPs significantly increased O 2 -levels along with a slight reduction of Mn-SOD expression. Since Mn-SOD is mainly expressed in mitochondria, it is plausible to hypothesize that this organelle plays a role in the control of oxidative stress in liver, as shown in rat skeletal muscle (27) . Septic MPs did not modify O 2 -production in the kidney despite an increase of Cu/Zn-SOD, which strengthened the notion that this organ is the least affected. Selenoenzymes such as glutathione peroxidase and thioredoxin are key players in the control of oxidative stress in sepsis. However, contradictory results have been reported with regard to sepsis (28, 29) .
Limitations of the Study. We have reported that MPs may be protective against vascular hyporeactivity by maintaining a vasoconstrictive response in patients with septic shock (10) . In the present study, under the same experimental conditions, septic MPs can induce oxidative and nitrative stresses and increase expression of proinflammatory enzymes in some target tissues, with the heart and lungs the most affected. The reasons for the differential effects of MPs might be due to tissue distribution, metabolism, or the nature of the target cells. In addition, it should be noted that the increase of nitration of proteins might imply not only an increase in peroxynitrite production, but also an enhanced activity of peroxidase enzymes. Also, the effects of septic MPs on proteins implicated in coagulation have not been explored, although it is well established that MPs carry tissue factor and that, in sepsis, activation of coagulation has been described (30) . Further studies are needed to sort out these underlying mechanisms. Nevertheless, we can conclude that MPs might participate in organ dysfunction observed in septic shock patients despite the reported correlation between in- 
